KORU Medical Systems, Inc.
KRMDNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M | $24.2M |
| Operating income | −$3.0M | −$6.4M | −$10.3M | −$10.8M | −$7.0M | −$1.3M |
| Net income | −$2.6M | −$6.1M | −$13.7M | −$8.7M | −$4.6M | −$1.2M |
| Total assets | $28.2M | $27.2M | $28.5M | $42.3M | $41.3M | $39.9M |
| Total liabilities | $11.2M | $10.4M | $8.1M | $11.0M | $4.8M | $3.8M |
| Equity | $17.0M | $16.8M | $20.4M | $31.3M | $36.5M | $36.2M |
| EPS (diluted) | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 |
| Shares out. | 46.0M | 45.7M | 45.5M | 44.7M | 44.5M | 39.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −7.2%
- Net margin
- −6.4%
- Return on equity
- −15.5%
- Return on assets
- −9.4%
- Return on capital (ROCE)
- −14.9%
- Liabilities / assets
- 39.5%
- Debt / equity
- 0.65×
- Book value / share
- $0.37
- Revenue growth (YoY)
- 22.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.06distress
- Accruals / assets
- −11.0%clean
- Beneish M-Score
- -2.89normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 2 warning● 4 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Jul 15, 2008
- NT 10-Kmissed a reporting deadline ↗May 29, 2008
- NT 10-Qmissed a reporting deadline ↗Jan 14, 2008
- NT 10-Qmissed a reporting deadline ↗Oct 15, 2007
- NT 10-Kmissed a reporting deadline ↗May 29, 2007
- NT 10-Qmissed a reporting deadline ↗Jan 16, 2007
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Blackrock, Inc.Passive (13G)Apr 27, 2026
- First Light Asset Management, LlcPassive (13G)Feb 17, 2026
- Topline Capital Management, LlcPassive (13G)Feb 13, 2026
- Horton Capital Partners, LlcActivist (13D)Feb 13, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 631,781 | 3.8 | +3.3% |
| Apr 30, 2026 | 611,911 | 5.6 | -17.0% |
| Apr 15, 2026 | 736,923 | 4.6 | -2.3% |
| Mar 31, 2026 | 754,466 | 5.0 | +18.3% |
| Mar 13, 2026 | 637,626 | 3.9 | -11.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 21, 2026
- Results of operationsMay 6, 2026
- Entered a material agreement · New financial obligationApr 3, 2026
- Director / officer changeMar 16, 2026
- Results of operationsMar 12, 2026
- Amended charter or bylawsFeb 11, 2026
- Results of operationsJan 12, 2026
- Entered a material agreementNov 25, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-K CURRENT REPORT FOR 05-19-2026May 21, 2026
- 4FORM 4 FOR 05-18-2026May 20, 2026
- 4/AFORM 4/A AMENDMENT NO. 1 FOR 05-15-2026May 20, 2026
- 4FORM 4 FOR 05-15-2026May 20, 2026
- 4FORM 4 FOR 05-14-2026May 19, 2026
- 4FORM 4 FOR 05-14-2026May 18, 2026
- 4FORM 4 FOR 05-14-2026May 18, 2026
- 4FORM 4 FOR 05-14-2026May 18, 2026
- 4FORM 4 FOR 05-14-2026May 18, 2026
- 144May 14, 2026
- 10-QFORM 10-Q QUARTERLY REPORT FOR 03-31-2026May 6, 2026
- 8-KFORM 8-K CURRENT REPORT FOR 05-06-2026May 6, 2026
- SCHEDULE 13G/AApr 27, 2026
- DEF 14ASCHEDULE 14A DEFINITIVE PROXY STATEMENTApr 9, 2026
- 4/AFORM 4/A AMENDMENT NO. 1 FOR 03-31-2026Apr 6, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.